4//SEC Filing
Ferrara Robert L 4
Accession 0001062993-25-009985
CIK 0001533040other
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:13 PM ET
Size
5.3 KB
Accession
0001062993-25-009985
Insider Transaction Report
Form 4
Ferrara Robert L
Director
Transactions
- Purchase
Common stock, $0.0001 par value
2025-05-20$1.82/sh+2,500$4,550→ 13,166 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at $1.82. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the transactions.
- [F2]Includes shares of common stock underlying unvested restricted stock units.
- [F3]The number of reported securities has been adjusted to reflect prior reverse stock splits.
Issuer
Phio Pharmaceuticals Corp.
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001792987
Filing Metadata
- Form type
- 4
- Filed
- May 20, 8:00 PM ET
- Accepted
- May 21, 4:13 PM ET
- Size
- 5.3 KB